Transcript Highlights:

• Generic or biosimilar drugs shall be placed on the list only if they have a wholesale acquisition cost

Keywords: 965, house, all

Transcript Highlights:

• The initial CalRx allocation was $50 million to manufacture three different biosimilar insulin products

Keywords: 988, house, all

Transcript Highlights:

• Civica has achieved several milestones in developing an affordable biosimilar insulin Largine product

Keywords: 988, house, all

Transcript Highlights:

• I know there are some biosimilar medication here that this body passed out seem to be kind of following
• I know there are some biosimilar medication here that this body passed out seem to be kind of following

Keywords: Meeting Start: 00:00:35 Attendance Roll Call: 00:00:55 Approval of Minutes: 00:02:56 Deferred Compensation Authority Update: 00:03:12 Retiree Health Update - TRS: 00:15:58 Retiree Health Update - KPPA: 00:56:13 Adjournment: 01:20:33, 958, all

Summary: The Public Pension Oversight Board received updates from the Kentucky Public Employees Deferred Compensation Authority and the Teachers Retirement System. Chris Biddle reported that deferred compensation assets had grown to about $4.787 billion with roughly 88,000 participants, crediting auto-enrollment, targeted marketing around pay raises, and retiree-focused services. He said the board’s self-directed brokerage account, authorized by last year’s legislation, is being designed around a $40,000 account-balance threshold with up to 25% transferable into the brokerage window, tentatively for July 1 of the coming year. He also described the free financial planning program, which has been used by about 3,300 to 3,500 participants with an 87% return rate, and noted that the plan is currently in a fee holiday; members asked about the fee structure and whether the CFP service is provided through Nationwide, which Biddle confirmed. Board members praised the deferred compensation program’s growth and asked for the legislation referenced by Biddle. He said the plan’s annual fees are capped, with a $1 monthly fee plus other charges up to a $225 cap, for a maximum of $237 per year absent a managed account. He also said the program is seeking unified payroll access to expand participation, especially among teachers, and that prior lineup changes saved about $6 million annually in participant fees. Bo Barnes of TRS then addressed retired teachers’ health insurance, first clarifying a prior question about declining federal contributions to the retirement annuity trust. He explained that federally funded school positions generated contributions that rose from $72 million in 2019 to $109 million in 2022, then fell to $85 million this year, with a projection of $80 million over the next three years; if those dollars do not come from federal sources, they would have to be replaced through the SEEK formula. Barnes then reviewed TRS health coverage, explaining that the statutory contract guarantees access to group coverage but not fixed premium levels, and that TRS administers two retiree plans: KEHP for retirees under 65 or otherwise not Medicare-eligible, and MEHP for retirees 65 and older or Medicare-eligible. Barnes said TRS completed RFPs for the 2026 plan year, retaining Express Scripts for prescription drugs and switching the Medicare Advantage medical provider from UnitedHealthcare to Humana, while keeping plan design, provider access, out-of-pocket costs, and benefits materially unchanged. He noted a modest hearing-aid improvement of $500 per ear beginning in 2026. He also reported that the TRS Board approved the maximum state contribution for KEHP at $1,044.96, up from $930.76, an 18% increase that he said would require about $15 million to $16 million more annually, while the MEHP premium would drop from $210 to $200 per month because of the new contract. Using the 2024 valuation, he said the KEHP increase would slightly reduce the health trust funded ratio from 80.4% to 80.1% and raise unfunded liability from $4.036 billion to $4.051 billion. Barnes closed by reviewing the 2010 shared-responsibility reforms that shifted retiree health costs away from a pay-as-you-go model, including phased employee and district contributions and Commonwealth stabilization funding. No votes were taken beyond approval of the minutes.

Transcript Highlights:

• In 2024 we took the prior authorization bill and we included Biosimilar or interchangeable biologics,

Bills: SB20, SB53, SB86, SB96, SB129

Keywords: prior authorization, pharmacy benefits manager, PBM, health insurer, prescription drugs, step therapy, formulary, auto-adjudication, electronic portal, appeals, medical necessity, serious mental illness, mental health, schizophrenia, bipolar disorder, major depression, substance use disorder, addiction treatment, cancer, autoimmune disorder

Transcript Highlights:

• It could be something also to deal with, maybe a biosimilar that came on the market and is more affordable

Bills: SB331, SB883, SB926, SB1137, SB1138, SB1144, SB1151, SB1236, SB1270, SB1522, SB1869, SB2207, SB2422

Keywords: healthcare, cost disclosure, transparency, administrative penalties, health facility compliance, COVID-19, off-label use, prescription drugs, patient access, medical standards, insurance, physician ranking, incentives, fiduciary duty, health plan issuers, SB 1137, group home, assisted living, residential care, board and care

Transcript Highlights:

• So the initial CalRx allocation was $50 million to manufacture three different biosimilar insulin products

Summary: The Assembly Budget Subcommittee on Health held an informational hearing on the Governor’s May Revision, focusing first on the Commission on Behavioral Health, then EMSA, and then the California Department of Public Health (CDPH). The Department of Finance said the state faces a third consecutive deficit and that the May Revision includes difficult trade-offs, including proposed eliminations or reversions of some behavioral health and public health funds. The LAO echoed concern about the structural deficit and said it was still awaiting some budget details before offering a full analysis. For the Commission on Behavioral Health, Finance proposed eliminating $20 million in Mental Health Wellness Act funds, arguing the money would help offset General Fund costs and noting future Proposition 1 innovation funding. The commission strongly opposed the cut, saying it would eliminate or delay launch-ready grants for early childhood supports, full-service partnerships, and peer respite, and would eventually end ongoing grant programming. Several advocates and commissioners testified that the funds support underserved communities and that Proposition 1 is not a substitute for the existing programs. The chair asked Finance to look for alternatives, but no vote was taken. EMSA presented mostly technical budget adjustments: increased authority for the California Poison Control System, a correction to EMSIS funding, and a reappropriation for enterprise services and data management. CDPH then reviewed a broader set of May Revision proposals, including reversions from the California Reducing Disparities Project, workforce development, STD prevention, hepatitis C prevention, hospice, and extreme heat funding, as well as a new generative AI pilot for health facility survey reporting. Members raised concerns about cuts to CRDP and gender health equity programs, especially because many grants are mid-contract and serve underserved communities; CDPH said the reversions were part of solving the deficit and that CRDP had been successful, while also clarifying that abortion.ca.gov would not be eliminated. Public comment was overwhelmingly opposed to the CRDP and related cuts, with many speakers describing the programs as life-saving and cost-effective. No formal votes or actions were taken during the hearing.

Transcript Highlights:

• finally if I know the origin of the current House Bill 117 to bring greater competition to the biosimilars
• finally if I know the origin of the current House Bill 117 to bring greater competition to the biosimilars
• finally, if I know the origin of the current House Bill 117 to bring greater competition to the biosimilars
• If I know the origin of the current House Bill 117 to bring greater competition to the biosimilars to
• If I know the origin of the current House Bill 117 to bring greater competition to the biosimilars to

Keywords: 1189, house, all

Transcript Highlights:

• make appropriate changes for safety and cost, including the use of generics and interchangeable biosimilars

Keywords: 988, house, all

Transcript Highlights:

• make appropriate changes for safety and cost, including the use of generics and interchangeable biosimilars

Summary: The committee heard several health-related bills. AB 1825 by Krell would clarify California’s offenders with mental health disorders program by tightening the standard for determining “substantial danger of physical harm,” improving exit planning, and expanding Medi-Cal access for people released after a successful challenge. Supporters, including psychiatrists, prosecutors, and medical groups, said the bill would close gaps in care and protect public safety; county behavioral health directors and Disability Rights California registered concerns. AB 1696 by Stephanie would state that nurse midwives do not need physician supervision when providing care within their existing scope, including EMTALA-related evaluation in labor and delivery settings. Nurse midwives and nursing groups supported the bill, while emergency physicians opposed it unless amended, arguing emergency department screening should remain under physician supervision; the author said she would keep working on the issue. AB 1949 by Lee would make acupuncture a separate Medi-Cal benefit and allow up to 24 visits per year. The author and supporters from acupuncture, health access, and integrative medicine groups said the current monthly cap is too restrictive and that acupuncture is an effective, cost-saving alternative for pain management and other conditions. There was no opposition. AB 2330 by Patterson would create a distinct regulatory category for cold spas, with standards for construction, operation, and disinfection. Fitness and wellness groups supported the bill, environmental health administrators had no formal position but thanked the author for amendments, and a committee member raised concerns about local officials interpreting the bill to require separate enclosures from saunas; the author said she would continue working on the language. AB 2000 by Aguirre-Curry would limit mid-year changes to prescription drug formularies and add notice, exceptions, reporting, and enforcement provisions. Family physicians, chronic care advocates, nurses, pharmacists, and patient groups supported the bill, citing non-medical switching and treatment disruptions; health plans and insurers opposed it, warning of higher costs, reduced flexibility, and premium increases. AB 1929 by Ortega would require health plans to disclose investments, including in private prisons and immigrant detention centers. Supporters framed it as a transparency measure tied to patient premiums and public values, while opponents argued the bill was duplicative, burdensome, and potentially harmful to investment confidentiality. AB 2746 by Schiavo would classify medical credit card debt as medical debt so it would not appear on credit reports. Consumer advocates and legal aid groups supported the bill, describing abusive marketing and housing harms; banks, debt collectors, and industry groups opposed it as unworkable and privacy-invasive. The committee took roll on AB 2746 and passed it on a due pass motion to Banking and Finance, with several members voting aye and a few no votes recorded.

Transcript Highlights:

• establish requirements, formulary placement, cost-sharing obligation for certain generic drugs, biosimilars

Bills: HR94, HR95, HR96, HR97, HR98, HR99, HR100, HR101, HR102, HR103, HR104, HR105, HR106, HR107, HR108, HR109, HR110, HR111, HCR45, HCR46, HCR47, HCR48, HCR49, HCR50, HR92, HR93, HCR44, SB11, SB72, SB78, SB151, SB207, SB210, SB219, SB241, SB286, SB324, SB351, SB376, SB409, SB411, HR74, HCR26, HB4, HB98, HB108, HB131, HB151, HB161, HB244, HB288, HB294, HB305, HB310, HB320, HB336, HB380, HB392, HB403, HB420, HB459, HB476, HB513, HB540, HB596, HB608, HB615, HB631, HB637, HB648, HB665, HB682, HB789, HB813, HB815, HB835, HB870, HB905, HB915, HB933, HB938, HB944, HB971, HB987, HB1040, HR15, HR20, HCR14, HCR6, HCR19, HCR10, HB81, HB134, HB154, HB163, HB170, HB194, HB217, HB220, HB254, HB259, HB290, HB308, HB311, HB360, HB382, HB401, HB410, HB417, HB463, HB575, HB592, HB718, HB723, HB750, HB755, HB776, HB812, HB844, HB882, HB888, HB961, HB966, HB980, HB54, HB67, HB73, HB125, HB133, HB158, HB168, HB169, HB191, HB195, HB245, HB280, HB283, HB296, HB319, HB339, HB399, HB407, HB448, HB550, HB591, HB826, HB995, HB1085, HB1086, HB722, HB140, HB468, HB546, HB746, HB842, HB923, HB166, HB349, HB352, HB429, HB436, HB588, HB747, HB780, HB782, HB911, HB827, HB953, HB796, HB901, HB9, HB52, HB58, HB193, HB284, HB400, HB570, HB577, HB582, HB605, HB733, HB735, HB868, HB952

Keywords: Sanfilippo Syndrome, awareness, genetic disorder, cognitive impairment, Louisiana, Alzheimer's, dementia, caregivers, public health, health education, civil bench warrants, judgment debtors, notification process, judgment debtor examination, Louisiana State Law Institute, Knock Knock Children's Museum, early childhood education, economic development, community engagement, Louisiana legislature

Summary: The House convened with a quorum, prayer, and the Pledge of Allegiance, then moved through a long morning of personal privileges, commemorations, and resolution introductions. Members recognized Coca-Cola United for its Louisiana economic impact and community work, designated April 7 as Coca-Cola Day, celebrated Ponchatoula Strawberry Festival Day, Dad’s Day, and other guests and honorees, including a science fair participant, Jack and Jill of America, and a birthday recognition. The House also introduced numerous resolutions on topics including awareness days, condolences, civic education, health, and local commemorations, and several were adopted or advanced without objection. The chamber then took up a series of bills and committee reports. Among the measures advanced were bills on constitutional convention procedures, criminal justice and post-conviction relief, public meetings, health care, education, insurance, natural resources, and local government. Several bills were reported favorably or with amendments and moved to third reading, including measures on school resource officers, pharmacy benefit managers, rural health clinics, the LSU Energy Institute, and live broadcasting of public meetings. The House also passed bills recreating the Department of Treasury, requiring cash acceptance or cash-to-credit options at state public facilities, funding municipal fire and police civil service administration, naming a highway segment for Sgt. Michael J. Guillory, and clarifying legislative review of certain contract amendments. Floor debate centered on a few substantive bills. HB 134, which would prohibit platforms from delivering pornography to minor accounts and authorize Attorney General enforcement, passed 98-0. HB 170, clarifying when the prescriptive period begins for certain construction-related claims, passed 89-7 after discussion of substantial completion and owner occupancy. HB 217, creating an optional property tax exemption for rehabilitation of blighted residential property, passed 83-13 after amendment. HB 259, addressing damage to infrastructure during broadband excavation and requiring notice, repair, and payment accountability, passed 98-0 after amendments. HB 308, requiring state public facilities to accept cash or provide a cash-to-credit machine, passed 98-0. HB 360, naming a highway memorial for Sgt. Michael J. Guillory, passed 101-0. HB 382, streamlining budget committee review of certain contract amendments, passed 96-0. The House also debated HB 410, a privacy bill requiring notice when a participant in a direct in-person conversation is being recorded, with exceptions for law enforcement, evidence of crime, and certain civil or administrative proceedings. Members raised concerns about the scope of the exceptions, undercover journalism, and the relationship to Louisiana’s one-party consent wiretapping law, but the bill’s sponsor said it would not change criminal wiretapping law and was modeled on other states’ approaches. The transcript ends during that debate, with no final vote shown for HB 410.

Transcript Highlights:

• It could be something also to deal with maybe a biosimilar came on the market, and it's more affordable

Bills: SB331, SB883, SB926, SB1137, SB1138, SB1144, SB1151, SB1236, SB1270, SB1522, SB1869, SB2207, SB2422

Keywords: healthcare, cost disclosure, transparency, administrative penalties, health facility compliance, COVID-19, off-label use, prescription drugs, patient access, medical standards, insurance, physician ranking, incentives, fiduciary duty, health plan issuers, SB 1137, group home, assisted living, residential care, board and care

Summary: The committee heard testimony on Senate Bill 883, which would protect physicians’ ability to prescribe off-label medications and treatments, framed by the author as a “Right to Treat” measure tied to COVID-19 care. Supporters, including physicians and patient-choice advocates, said the bill would safeguard the doctor-patient relationship and prevent interference by boards, pharmacies, or hospitals. Several witnesses described using hydroxychloroquine, ivermectin, budesonide, antibiotics, steroids, and monoclonal antibodies during the pandemic, and said they faced complaints, board scrutiny, or pharmacy refusals for those prescriptions. The bill was left pending after public testimony closed. The committee then took up Senate Bill 331, which would extend hospital price-transparency requirements to additional health care facilities such as freestanding ERs, urgent care and retail clinics, ambulatory surgical centers, outpatient clinics, and birthing centers. Proponents argued that broader disclosure of prices for shoppable services would help consumers compare costs and reduce surprise billing, while opponents from ambulatory surgery centers said the bill would impose costly compliance burdens on small providers and that insurers or the state already have much of the needed data. The bill was also left pending. Senate Bill 2422 would expunge Texas Medical Board records and impose reparations for disciplinary actions tied to COVID-era treatment decisions, including references to ivermectin, hydroxychloroquine, budesonide, and masks. The author and supporters argued that doctors were unfairly targeted for trying to save patients and should be made whole; the Texas Medical Board representative said most pandemic complaints were dismissed, that actions generally involved broader issues such as privileges, documentation, or informed consent, and that no physician was disciplined solely for prescribing off-label COVID medications. The bill was left pending. Finally, the committee heard Senate Bill 2207, which would loosen Texas Medical Board rules on physicians advertising themselves as board certified, especially by reducing barriers tied to maintenance of certification requirements. Supporters said the current rule is overly restrictive, inconsistent, and costly, and that it drives physicians out of practice; they also said Texas is one of only a few states with such a rule. Witnesses described hospitals using the rule against physicians and said the change would improve transparency and competition. The bill remained pending after testimony.

Transcript Highlights:

• , developed some better and more technically accurate language on the subject of biological and biosimilar
• :58:39.119><c> of</c><01:58:39.360><c> biological</c><01:58:40.000><c> and</c><01:58:40.159><c> biosimilar
• </c> subject of biological and biosimilar subject of biological and biosimilar drugs.<01:58:41.840><c

Keywords: 1191, senate, all

Transcript Highlights:

• establish requirements for formulary placement, cost-sharing obligations for certain generic drugs and biosimilars

Bills: HR94, HR95, HR96, HR97, HR98, HR99, HR100, HR101, HR102, HR103, HR104, HR105, HR106, HR107, HR108, HR109, HR110, HR111, HCR45, HCR46, HCR47, HCR48, HCR49, HCR50, HR92, HR93, HCR44, SB11, SB72, SB78, SB151, SB207, SB210, SB219, SB241, SB286, SB324, SB351, SB376, SB409, SB411, HR74, HCR26, HB4, HB98, HB108, HB131, HB151, HB161, HB244, HB288, HB294, HB305, HB310, HB320, HB336, HB380, HB392, HB403, HB420, HB459, HB476, HB513, HB540, HB596, HB608, HB615, HB631, HB637, HB648, HB665, HB682, HB789, HB813, HB815, HB835, HB870, HB905, HB915, HB933, HB938, HB944, HB971, HB987, HB1040, HR15, HR20, HCR14, HCR6, HCR19, HCR10, HB81, HB134, HB154, HB163, HB170, HB194, HB217, HB220, HB254, HB259, HB290, HB308, HB311, HB360, HB382, HB401, HB410, HB417, HB463, HB575, HB592, HB718, HB723, HB750, HB755, HB776, HB812, HB844, HB882, HB888, HB961, HB966, HB980, HB54, HB67, HB73, HB125, HB133, HB158, HB168, HB169, HB191, HB195, HB245, HB280, HB283, HB296, HB319, HB339, HB399, HB407, HB448, HB550, HB591, HB826, HB995, HB1085, HB1086, HB722, HB140, HB468, HB546, HB746, HB842, HB923, HB166, HB349, HB352, HB429, HB436, HB588, HB747, HB780, HB782, HB911, HB827, HB953, HB796, HB901, HB9, HB52, HB58, HB193, HB284, HB400, HB570, HB577, HB582, HB605, HB733, HB735, HB868, HB952

Keywords: Sanfilippo Syndrome, awareness, genetic disorder, cognitive impairment, Louisiana, Alzheimer's, dementia, caregivers, public health, health education, civil bench warrants, judgment debtors, notification process, judgment debtor examination, Louisiana State Law Institute, Knock Knock Children's Museum, early childhood education, economic development, community engagement, Louisiana legislature

Transcript Highlights:

• They added a definition of biosimilar or biosimilarity, and they also tweaked the definition of interchangeable

Keywords: 1189, house, all

Transcript Highlights:

• taxpayers, and there was a savings of about $2.4 to $2.5 million in one of their recommendations to do biosimilars
• The speaker added that, specifically on the question, the recommendation to use biosimilars in the clinical
• been brought to his attention that the person who is the motivation behind the bill to use the biosimilar
• You've heard me talk about biosimilars and Humira and how that was, uh, had the PAB repositioned that

Keywords: 928, house, all

Summary: The committee first considered House Bill 66, a right-to-know measure that would broaden access from “citizen” to “person,” including out-of-state requesters. Members also adopted an amendment removing the current no-filing-fee provision for appeals of unfavorable right-to-know ombudsman rulings, citing budget concerns. The bill was then reported ought to pass as amended on a 16-9 vote, with a minority report requested. House Bill 187, which would let a parent or guardian seek a protective order on behalf of a minor alleging abuse by someone outside the family or household, was described as a narrow fix with little fiscal impact. It passed unanimously, 25-0, and was placed on the consent calendar. House Bill 215, requiring landfill permit applicants to submit a report on potential harms and benefits, was retained because its policy had been folded into House Bill 2; the committee voted 25-0 to retain it. House Bill 219, dealing with renewable portfolio standard changes and lower renewable energy certificate values, drew opposition from members who said it would weaken renewable energy development and raise concerns about energy costs, but the motion to retain was adopted 14-11, allowing the bill to be moved into House Bill 2. The committee then retained House Bills 365, 552, 566, 572, 607, 611, and 624, all by unanimous or near-unanimous votes, generally because the relevant policy or funding had been incorporated into House Bill 2 or because the bills were viewed as technical or low-impact. HB 566 was described as a landfill leach-management bill with a fiscal note under $10,000 annually and was sent to consent. HB 572 and HB 607 were retained because their money components were moved into HB 2, though one member objected that HB 607 represented an unfunded mandate for the Hampton Beach Area Commission. House Bill 511, concerning ICE detainers and county detention practices, generated the most debate. Supporters said the amendment clarified how long counties may hold detainees without a federal contract and compared the detention period to existing bail rules; opponents argued the bill could sanction detention of people not charged with crimes and raised due-process concerns. The committee adopted the amendment 14-11 and then reported the bill ought to pass as amended on another 14-11 vote, with a minority report requested. House Bill 639, involving securities and digital currency issues, was also reported ought to pass after members noted unresolved concerns but said the Secretary of State’s Securities Division was willing to continue working on it in the other body; the vote was 16-10.

Transcript Highlights:

• The one thing that we're hearing from our actuaries is that the GLP-1 drug, because there's more biosimilars

Keywords: 959, house, all

Transcript Highlights:

• And after that, it becomes available to generics in the case of a synthetic drug or to biosimilars in

Bills: HB 44, HB 2200, HB 1612, HB 2747, HB 2038, HB 3717, HB 1431, HB 3800, HB 3801, HB 3560, HB 3246

Keywords: HB 44, Life of the Mother Act, abortion exceptions, medical emergency, reasonable medical judgment, pregnancy complications, maternal health, life-threatening condition, ectopic pregnancy, miscarriage, spontaneous abortion, fetal survival, Texas abortion law, abortion ban, physician liability, health care provider, disciplinary action, aiding and abetting, emergency abortion, obstetric care

Summary: The meeting of the public health committee focused on the pressing issue of opioid addiction in Texas, with a particular emphasis on House Bill 3717. Chairman Harris detailed the bill's intent to fund a grant program for Ibogaine clinical trials, framing it as a critical response to the ongoing opioid crisis. He shared poignant testimonies highlighting the struggles of families and veterans battling addiction and mental health issues. The conversation underscored the necessity of innovative treatments, like Ibogaine, which showed promising results in studies for reducing symptoms of withdrawal and PTSD.

Transcript Highlights:

• avoidance to plan sponsors when we use affiliated manufacturers, which is usually set with the use of biosimilars

Summary: The Appropriations Committee considered a large agenda of bills and reported several measures favorably. Early action included SB 6, a settled claim bill involving the Department of Children and Families and a trust for Leila Estrada and Sapphire Williams, and CS/CS/SB 1266, which creates a cybersecurity experiential learning and clearance-readiness program through the Department of Commerce and Cyber Florida. The committee also approved SB 532 on clerks of court funding, allowing clerks to retain all excess Article V revenue rather than returning half to the state and clarifying foreclosure sale procedures. In addition, the committee passed CS/CS/SB 1602 and CS/CS/SB 1604 to create and fund a pilot housing program for veterans through the Florida Housing Finance Corporation, and CS/SB 1110 to expand Medicaid and private insurance coverage for medically necessary orthotics and prosthetics, including testimony from affected families and advocates. The committee also adopted an amendment and then favorably reported CS/CS/SB 1012 on inmate services, removing the bill’s medical-services compensation provisions while retaining changes to the inmate welfare trust fund and related facility uses. It also adopted a delete-all amendment and then favorably reported CS/CS/CS/SB 1614, which was narrowed to remove a provision allowing local governments to use excess fees to construct new buildings. The committee spent substantial time on CS/SB 17, a Medicaid oversight and transparency bill. The sponsor said the measure would create a joint legislative Medicaid oversight committee, authorize the Legislature to retain its own actuary, modernize Medicaid statutes, strengthen managed-care performance standards, and increase accountability for pharmacy benefit managers and related entities. After amendment, the committee adopted changes removing several PBM-related provisions while retaining the broader oversight framework. Testimony from supporters emphasized transparency, fraud prevention, and cost control, while a PBM trade association asked to continue working on affiliate-manufacturer, network, and payment issues. The bill was reported favorably. The most extensive discussion centered on CS/SB 1758, which proposes major changes to Medicaid and SNAP. The sponsor described five reforms: stronger fraud and overpayment recovery authority, a Medicaid work requirement for certain able-bodied adults, expanded behavioral-health services through Medicaid waivers, pharmacy-program changes to obtain rebates and reduce institutional costs, and SNAP/EBT reforms including photo IDs and work requirements. The committee adopted two amendments: one adding a transitional “glide path” for people who gain employment but risk losing Medicaid, and another exempting hospice patients with six months or less to live. Supporters argued the bill would reduce fraud, improve accountability, and encourage work, while opponents warned it would increase administrative burdens, push eligible people off coverage, and conflict with federal law or guidance. The bill remained under debate with extensive public testimony from advocates, providers, and affected families, and the transcript ends before final disposition on the measure.

Transcript Highlights:

• avoidance to plan sponsors when we use affiliated manufacturers, which is usually set with the use of biosimilars

Keywords: 999, senate, all

Summary: The committee took up a large appropriations agenda and reported several bills favorably, including a claims bill for relief of Leila Estrada/Sapphire Williams against DCF (SB 6), a cybersecurity internships and clearance-readiness program with the Department of Commerce and Cyber Florida (CS/CS/SB 1266), a clerks of court funding measure allowing clerks to retain more excess revenue and clarifying foreclosure-sale procedures (CS/CS/SB 532), and a veterans housing pilot program and related trust fund for certain counties (CS/CS/SB 1602 and CS/CS/SB 1604). It also approved a bill expanding Medicaid and private insurance coverage for orthotics and prosthetics, including activity limbs for children and disabled adults (CS/SB 1110), with emotional testimony from affected families and support from several senators. The committee also adopted amendments and favorably reported a corrections-related bill after removing provisions on inmate emergency and specialty medical services (CS/CS/SB 1012), and a local-government/JLAC-related bill that was narrowed by delete-all amendment to address use of excess fees for new construction (CS/CS/CS/SB 1614). A Medicaid oversight and pharmacy transparency bill (CS/CS/SB 17, referred to in the roll as CS/CS/SB 1760) also advanced after amendment, with debate focused on PBM practices, managed care transparency, and oversight of Medicaid spending. The most extensive debate centered on SB 1758, a broad public assistance reform bill. The bill would direct agencies to pursue Medicaid fraud recovery, impose work requirements for certain able-bodied Medicaid recipients, expand behavioral health services through waivers, modernize Medicaid drug purchasing, and require SNAP fraud-reduction measures including photo ID on EBT cards and updated work requirements. Supporters argued it would reduce fraud, improve accountability, and save money, while opponents warned it would create administrative burdens, increase paperwork, and risk coverage loss for vulnerable Floridians, especially because Florida has not expanded Medicaid. The committee adopted amendments adding a transitional medical benefits “glide path” for people who gain employment and an exemption for hospice patients, but the bill drew significant opposition from advocacy groups, who questioned the legality, cost, and practical implementation of the work requirements and SNAP changes. No final vote on SB 1758 is reflected in the transcript excerpt.